Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-02
2006-05-02
Aulakh, Charanjit S. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S081000, C546S080000
Reexamination Certificate
active
07038051
ABSTRACT:
Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
REFERENCES:
patent: 3314941 (1967-04-01), Littell et al.
patent: 3764681 (1973-10-01), Dreikom
patent: 3917624 (1975-11-01), Abu El-Haj et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5175296 (1992-12-01), Gerster
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster
patent: 5268376 (1993-12-01), Gester
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5367076 (1994-11-01), Gerster
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5693811 (1997-12-01), Lindstrom
patent: 5741908 (1998-04-01), Gerster
patent: 5756747 (1998-05-01), Gerster
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6069149 (2000-05-01), Nanba et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6514985 (2003-02-01), Gerster et al.
patent: 6518265 (2003-02-01), Kato et al.
patent: 6518280 (2003-02-01), Gerster et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6624172 (2003-09-01), Lindstrom et al.
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6693113 (2004-02-01), Lindstrom
patent: 6706728 (2004-03-01), Hedenstrom et al.
patent: 6743920 (2004-06-01), Lindstrom et al.
patent: 6747040 (2004-06-01), Lindstrom et al.
patent: 6756382 (2004-06-01), Coleman et al.
patent: 6797718 (2004-09-01), Dellaria et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 6894165 (2005-05-01), Gerster et al.
patent: 2002/0016332 (2002-02-01), Slade
patent: 2002/0055517 (2002-05-01), Smith
patent: 2002/0110840 (2002-08-01), Tomai et al.
patent: 2003/0130299 (2003-07-01), Crooks et al.
patent: 2003/0133913 (2003-07-01), Tomai et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0161797 (2003-08-01), Miller et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski et al.
patent: 2004/0014779 (2004-01-01), Gorden et al.
patent: 2004/0091491 (2004-05-01), Kedl et al.
patent: 2004/0132079 (2004-07-01), Gupta et al.
patent: 2004/0141950 (2004-07-01), Noelle et al.
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0162309 (2004-08-01), Gorden et al.
patent: 2004/0171086 (2004-09-01), Fink et al.
patent: 2004/0175336 (2004-09-01), Egging et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0180919 (2004-09-01), Lee et al.
patent: 2004/0181130 (2004-09-01), Fox et al.
patent: 2004/0181211 (2004-09-01), Elliott et al.
patent: 2004/0191833 (2004-09-01), Fink et al.
patent: 2004/0192585 (2004-09-01), Fox et al.
patent: 2004/0197865 (2004-10-01), Gupta et al.
patent: 2004/0202720 (2004-10-01), Wightman et al.
patent: 2004/0214851 (2004-10-01), Birmachu et al.
patent: 2005/0054590 (2005-03-01), Averett
patent: 0 394 026 (1990-10-01), None
patent: 1 104 764 (2001-06-01), None
patent: 9-208584 (1997-08-01), None
patent: 9-255926 (1999-03-01), None
patent: 11-222432 (1999-08-01), None
patent: 2000-247884 (2000-09-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 03/097641 (2003-11-01), None
patent: WO 04/091500 (2004-10-01), None
Wozniak, et al, “The Amination of 3-nitro-1, 5-naphthyridines by Liquid Ammonia/Potassium Permanganate1,2. A New and Convenient Amination Method.”,Journal of the Royal Netherlands Chemical Society,102, pp 511-513, Dec. 12, 1983.
Brennan, et al, “Automated Bioassay of Interferons in Micro-test Plate”,Biotechniques,Jun./Jul., 78, 1983.
Testerman, et al., “Cytokine Induction by the Immunomodulators Imiquimod and S-27609”,Journal of Leukocyte Biology,vol. 58, pp. 365-372, Sep. 1995.
Bachman, et al, “Synthesis of Substituted Quinolylamines. Derivatives of 4-Amino-7-Chloroquinoline”,J. Org. Chem,15, pp 1278-1284 (1950).
Jain, et al, “Chemical and Pharmacological Investigations of Some ω-Substituted Alkylamino-3-aminopyridines”,J. Med. Chem.,11, pp 87-92 (1968).
Baranov, et al.,Chem. Abs.85, 94362, (1976).
Berényi, et al, “Ring Transformation of Condensed Dihydro-as-triazines”,J. Heterocyclic Chem., 18, pp 1537-1540 (1981).
Chollet, et al, “Development of a Topically Active Imiquimod Formulation”,Pharmaceutical Development and Technology,4(1), pp 35-43 (1999).
Izumi, et al., “1H-Imidazo[4,5-c]quinoline Derivatives as Novel Potent TNF-α Suppressors: Synthesis and Structure-Activity Relationship of 1-,2- and 4-Substituted 1-H-imidazo[4,5-c]pyridines”,Bioorganic&Medicinal Chemistry, 11, pp 2541-2550 (2003).
Hart, E.P. “Napthyridines. Hydroxynaphthyridies”,Journal of Chemical Society, Part III, pp 212-214 (1956).
Crooks Stephen L.
Gerster John F.
Heppner Philip D.
Lindstrom Kyle J.
Marszalek Gregory J.
3M Innovative Properties Company
Aulakh Charanjit S.
Ersfeld Dean A.
LandOfFree
Imidazonaphthyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazonaphthyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazonaphthyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3548138